Manufacturing News of Note—Olon starts new facility; Hikma signs on with Civic Rx


> Italy-based CDMO Olon has started construction of new manufacturing facility at its microbial CDMO facility located in Capua, Italy. Release

> Hikma Pharmaceuticals has become the latest CDMO to sign a deal with Civica Rx, the hospital-controlled company that is helping healthcare providers get drugs that are often in short supply. Release

> WuXi STA says its Analytical Service Unit in Shanghai and active pharmaceutical ingredient process R&D and manufacturing facility in Changzhou both successfully passed two inspections from the U.S. FDA. Release

> The CPhI and P-MEC China trade show in China saw record numbers, reflecting the surge of interest in manufacturing products in that country. Release 



Suggested Articles

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

AstraZeneca and Oxford BioMedica have inked a deal to produce commercial and clinical supply of the University of Oxford's COVID-19 shot hopeful.